Posted on 7 月 22, 20247/22/24
PDURS Explained: The FDA’s New Framework for Adding Software to Drug Labels
Posted on 7 月 17, 20247/17/24
In-Depth with an Industry Leader: Global Launch Ambitions and Paradigm Shifts
Posted on 7 月 8, 20247/8/24
Report: Integrated Delivery Network Trends and Engagement Strategies Every Drug Manufacturer Needs to Know
Posted on 6 月 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
Posted on 6 月 28, 20246/28/24
Strategic Launch: Accelerating Innovative Therapies in the Chinese Market
Posted on 6 月 24, 20246/24/24
Market Access and the Inflation Reduction Act
Posted on 6 月 21, 20246/21/24
Optimizing Product Commercialization in Today’s IDN Environment
Posted on 5 月 31, 20245/31/24
M&A and BD&L Outlook and Perspectives on Commercial Due Diligence
Posted on 5 月 23, 20245/23/24
Bridging “Share of Voice” with “Share of Influence” for Lasting Impact
Posted on 5 月 23, 20245/23/24